These people would otherwise rely on the availability of daily B12 shots to counter their inability to absorb B12 through the gut
R.LiL.PopeS.et al (2015)
Final research-target dose 2.4 mg + 2.4 mg weekly Titration length ~16 weeks Trial duration 68 weeks (REDEFINE 1 / REDEFINE 2) Route Subcutaneous, once weekly Compound Delivery: 2.4 mg / 2.4 mg Maintenance Pre-blended vials simplify weekly administration to a single injection but lock the ratio at 1:1
And now you are standing in your kitchen, syringe in hand, wondering whether this expired tirzepatide will still work or whether it could actually hurt you
RETA RETA RETA RETA RETA RETA Disguised Alpha Research Profile GLP-3 Reta is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
This article incorporates text from this source, which is in the public domain